Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New mapping technique may improve heart rhythm procedure

NCT ID NCT03915691

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This study tests two ways to do a catheter ablation for a type of fast heartbeat called atrial tachycardia that comes from heart scar tissue. One method uses a new mapping system (Ripple Mapping) to guide the ablation, while the other uses the standard approach. The goal is to see which method better prevents the arrhythmia from coming back within a year. About 200 adults who need this procedure are taking part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL TACHYCARDIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Freeman Hospital, The Newcastle Upon Tyne NHS Foundation Trust

    Newcastle, NE7 7DN, United Kingdom

  • Imperial College Healthcare NHS Trust

    London, W12 0HS, United Kingdom

  • Liverpool Heart & Chest Hospital

    London, L14 3PE, United Kingdom

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Catheter ablation (Ripple Mapping guided or conventional mapping guided)

What this could lead to

If successful, this could identify a more effective ablation technique to reduce the return of atrial tachycardia after the procedure.

What could go wrong

This is a mid-stage study with no phase designation, and the outcome depends on long-term follow-up. The procedure itself carries standard risks like bleeding or heart damage.

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.